Access cutting-edge parkinson disease (disorder) treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this St Louis location
Preparing your pre-screening questions…
Access parkinson disease (disorder) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related parkinson disease (disorder) treatment provided free
Check if you qualify for this parkinson disease (disorder) clinical trial in St Louis, MO
No-Cost Study Care
Local to St Louis
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Mild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem. Unfortunately, existing cognitive interventions for PD, which focus on restoring deficient cognitive skills through cognitive training (repetitive practice of tasks that challenge specific cognitive skills), provide limited benefit for daily function and QOL. To overcome this limitation, the investigators use strategy training. the investigators help people develop targeted strategies to use in everyday life to circumvent cognitive deficits and accomplish daily activities. Contemporary cognitive rehabilitation evidence supports strategy training for other neurological conditions and mild cognitive impairment (MCI), but it has not been well-studied in PD. By teaching strategies for everyday cognition, the investigators hypothesize that our interventions will improve functional outcomes for people with PD. Study participants will complete a baseline cognitive testing session, 10 cognitive treatment sessions with a trained occupational therapist, then have follow-up visits with the study team at 1-week, 3-months, 6-months, and 12-months after completing the study intervention.
Sponsor: Washington University School of Medicine
Yes, this clinical trial (NCT07190404) has an active research site in St Louis, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for parkinson disease (disorder) treatment options in St Louis, MO, this clinical trial (NCT07190404) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson disease (disorder) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all parkinson disease (disorder) clinical trials near you to find additional studies recruiting in your area.
See all parkinsons disease clinical trials recruiting in St Louis — not just this study.
Browse Parkinsons Disease Trials in St Louis →